Introduction
============

Chagas disease represents an infectious condition classified by the World Health Organization (WHO) as a neglected illness. It is caused by the protozoan *Trypanosoma cruzi* and presents several symptoms, leading to a continuous inflammatory process that results in the replacement of functional health tissues by connective tissue, and thereafter, function loss of tissues and organs, which may lead to death ([@B69], [@B70]; [@B61]; [@B65]; [@B37]; [@B44]).

Studies in *T. cruzi* experimental infection models have established a strong immunological response in the acute phase, characterized by an intense infiltration of activated macrophages with the ability to process and present antigens, cytokines synthesis, and give co-stimulatory signals demonstrating their essential function in innate immune responses, in order to control the parasite multiplication and elimination ([@B70]). A distinguishing aspect of Chagas disease-triggered macrophages is the increased numbers of distinct cytoplasmic organelles called lipid bodies (LBs) (**Figure [1](#F1){ref-type="fig"}**) ([@B49]; [@B20]).

![Lipid bodies (LBs) biogenesis and components in both the host cell cytoplasm during the interaction and/or infection with *T. cruzi* and in the trypomastigotes forms of *T. cruzi*. **(A)** LBs accumulation (green) in murine infected macrophage after staining with BODIPY^®^ 493/503. Nuclei of macrophage and internalized parasites were stained with DAPI (4′,6-diamidino-2-phenylindole; blue). **(B)** Schematic representation of the structural composition of a LB. Colored objects represent LBs surface-bound proteins located in the phospholipid monolayer. Prostaglandin E2 (PGE) 2, arachidonic acid (AA), diacilclycerols (DAG), triacylglycerols (TAG), and cholesterol esters (CE) are found in the neutral lipid core. **(C)** Electron micrograph showing a LB in the trypomastigote form of *T. cruzi*. From: Melo, RCN (courtesy); Toledo, DAM and D'Avila, H.](fmicb-09-00499-g001){#F1}

Lipid bodies are lipid rich-organelles that have been found in almost all organisms from bacteria to humans ([@B5]; [@B75]; [@B56]). In mammalians, LBs are found in the major part of leukocytes and other cellular types, such as endothelial cells, fibroblasts, and mastocytes ([@B27]; [@B11]) and can be involved directly or indirectly in numerous cellular functions, such as lipid metabolism, membrane traffic, intracellular signaling and the production of several inflammatory mediators ([@B11]). LBs within infected cells are involved in the production of inflammatory mediators which can potentially inhibit the host Th1 response, thus, modulating parasite growth ([@B67]; [@B39]). Interestingly, a recent study established that *T. cruzi* LBs are also active and producing immunosuppressive inflammatory mediators which may represent not only an evasion strategy but also a survival factor exhibited by the parasite ([@B71]).

The purpose of this mini review is to present the recent progress in elucidating the structure, formation mechanisms and functions of intracellular LBs within both infected host cells and the protozoan parasite *T. cruzi*, as well as their impact on the host response and parasite escape mechanism during Chagas disease.

Lipid Body Characterization and Structure
=========================================

Lipid bodies, also known as lipid droplets or adiposomes, are multi-functional organelles associated with lipid homeostasis in virtually all cells (**Figure [1](#F1){ref-type="fig"}**). Although, the cellular and molecular mechanisms of LBs biogenesis remain to be determined; it is currently known that the endoplasmic reticulum (ER) structure may have an important role during LB biogenesis. In eukaryotic cells, LBs are formed *de novo* from the ER ([@B38]; [@B40]; [@B19]). The most accepted model suggests that it was as a *building model*, where enzymes, such as diacyltransferase DGAT1 and DGAT2, produce triacylglycerols (TAG). Moreover, these enzymes are involved in lipid metabolism localized in specific compartments of the ER, favoring the synthesis of neutral lipid between the two membrane leaflets of the ER, producing a hydrophobic neutral lipid core ([@B57]; [@B10]; [@B76]). After reaching a determined size, nascent LBs carried with proteins lacking trans-membrane spanning domains bud off from ER into the cytoplasm and finally the lipids are coated by a phospholipid monolayer from the cytoplasmic leaflet of the ER membrane ([@B54], [@B55]; [@B46]; [@B10]; [@B76]).

In general, the LB structure consists of a neutral lipid core, containing TAG and cholesterol ester (CE) in its majority, surrounded by an outer monolayer of phospholipids because LBs besides being heterogeneous organelles also lack a true delimiting unit membrane structure ([@B68]). Moreover, LBs are structured by perilipin (PLIN) family proteins, including perilipin/PLIN1, PLIN2/ADRP (adipose differentiation-related protein), PLIN3/TIP47 (tail-interacting protein of 47 KDa) (**Figure [1B](#F1){ref-type="fig"}**) ([@B15]; [@B81]; [@B23]; [@B80]). The protein content can be diverse once proteomic studies have shown ribosomal, mitochondrial, and vesicular transport proteins, such as Ras-associated binding protein (RAB)s, ADP-ribosylation factor (ARF)s, caveolins and ER components compartmentalized in the LBs, suggesting their role in fusion and fission with other LBs or organelles, as well as cell signaling and inflammatory mediator proteins under different conditions. However, the lipid and protein content depend on the cell type and condition of the cellular activation ([@B27]; [@B14]; [@B85], [@B86]; [@B82]; [@B31]; [@B18]; [@B72]; [@B59]; [@B8]; [@B9]; [@B36]).

Lipid Body Formation During *T. cruzi* Infection
================================================

The mechanism of formation of LBs in host cells is a highly regulated event. Upon leukocytes activation LBs are formed rapidly in response to different stimuli and pathological conditions, such as infection by distinct pathogens: mycobacteria ([@B17]; [@B21]; [@B4], [@B3]; [@B47], [@B48]), virus ([@B29]) or protozoan, such as *T. cruzi* ([@B49]; [@B20]), *Leishmania major* ([@B63]), *L. amazonensis* ([@B62]; [@B43]), and *Toxoplasma gondii* ([@B32]; [@B53]).

During *in vivo* studies in *T. cruzi* infection, it was demonstrated that this disease promotes an important inflammatory response featured by intense macrophage migration to the infectious sites, mainly the heart ([@B51]; [@B49]). [@B50] showed LBs enhancement in inflammatory macrophages associated with increased myocardial parasitism ([@B50]). Moreover, during *T. cruzi* infection, LBs show a diversity electron-density, which suggest a diverse composition associated with recruitment and/or *in situ* production of lipid inflammatory mediators ([@B49], [@B50]).

In macrophages, the *T. cruzi* internalization potentiates LB biogenesis; however, the phagocytosis is neither sufficient nor essential for triggering the biogenesis. It has been demonstrated that after a 24 h period of infection with *T. cruzi*, peritoneal macrophages with internalized parasites, as well as non-parasitized cells show increased number of LBs compared to control ([@B20]). Although not fully elucidated, the formation of LBs in host macrophages seems to involve the pathogen recognition by surface receptors, as well as paracrine signaling that soluble factors secreted by parasites or infected cells might induce LB biogenesis in non-parasitized cells.

Our group demonstrated that, in murine macrophages, the *in vitro T. cruzi* infection induced LBs formation through recognition via toll like receptor 2 (TLR-2) (**Figure [2](#F2){ref-type="fig"}**) ([@B20]). In fact, some groups of researchers have identified different molecular motifs from this parasite able of activating TLRs in macrophages, such as Glycosylphosphatidylinositol-anchored mucin-like glycoproteins (tGPI-mucin) present in the parasite membrane and capable of inducing the inflammatory response through an activation of TLR2 ([@B2]; [@B16]; [@B33]). However, the identification of downstream signaling pathways involved in this processes during *T. cruzi* infection needs to be more elucidated. TLR4 has also been involved in the immune response during the first stage of infection ([@B64]); nonetheless, it was not able to mediate the LB formation in macrophages ([@B20]).

![Lipid bodies formation in response to interaction macrophage- *T. cruzi* favors parasite replication. The uptake of trypomastigotes through TLR2 induces LBs formation in macrophages, which is potentiated by phagocytosis of apoptotic cells through αvβ3 receptor. The interaction of parasite--macrophage also induces LBs accumulation in extracellular trypomastigotes and intracellular amastigotes, which can serve as lipid sources for parasite growth. In addition, the TGF-β produced by infected macrophages acts autocrinally contributing for LBs increase. New formed LBs from parasite and macrophage are sites for PGE~2~ synthesis, because they compartmentalize the substrate (AA) and the enzymes as (COX-2 and PGE~2~ synthase) for their production. PGE~2~ is a potent lipid mediator that, together with TGF- β, potentially reduces the host Th1 immune response, thus decreasing the microbicidal capacity of the macrophage. The macrophages treatment with Aspirin, NS-398 or C75 can inhibit LBs accumulation and LBs-derived PGE~2~ synthesis, controlling the parasite replication. AA, arachidonic acid; COX-2, cyclooxygenase -2, TGF-βR, TGF- βR receptor.](fmicb-09-00499-g002){#F2}

During *T. cruzi* infection, the induction of apoptosis, especially of T and B lymphocytes ([@B30]; [@B26]) and neutrophils ([@B45]) represents an important mechanism that contributes to the parasite replication, due to the immunomodulatory effects on the host immune response ([@B25]). Consequently, the efferocytosis or phagocytic clearance of these apoptotic cells by macrophages has profound consequences on innate and adaptive immune responses in inflamed tissues ([@B28]). Moreover, it has been shown that the formation of LBs during *T. cruzi* infection in macrophages is potentiated in the presence of apoptotic, but not necrotic or living cells ([@B20]).

The uptake of apoptotic cells through the α~v~β~3~ integrin (vitronectin receptor) is critical in the induction of LBs during *T. cruzi* infection (**Figure [2](#F2){ref-type="fig"}**). In addition, the treatment with flavoridin, a desintegrin that blocks binding via a~v~β~3~, completely abolished the LB-formation induced by the apoptotic cells uptake ([@B20]). Furthermore, some groups have shown that the interaction of apoptotic cells and phagocytic cells induces the production of cytokines such as IL-10 and TGF-β ([@B74]; [@B83], [@B84]) causing these cells to be more permissive to *T. cruzi* infection ([@B30]; [@B20]). Studies *in vitro* have shown that the TGF- β produced by macrophages could induce LBs in these cells. The use anti-TGF β1 neutralizing antibody inhibited the secretion of TGF- β, and abolished the LB formation induced by this cytokine, demonstrating that this mediator can directly trigger LB formation (**Figure [2](#F2){ref-type="fig"}**) ([@B20]). Even though the attachment of other co-receptors cannot be ruled out, these data suggest that efferocytosis by macrophages through α~v~β~3~ receptor triggers TGF-β1-dependent potentiating the LB biogenesis.

Lipid Body Formation in the Protozoan *T. cruzi*
================================================

In recent years, it has become of interest the study of the biogenesis, structure, composition, and function of LBs formed within protists parasites, such as *T. cruzi*. These parasites are able to acquire host lipids or to codify their own lipid biosynthesis machinery, thus allowing LBs biogenesis independently of their host ([@B22]; [@B35]).

[@B71] showed that metacyclic trypomastigote forms from *T. cruzi*, co-cultured with peritoneal macrophages for 1 h had enhanced LB biogenesis, suggesting that the interaction of infective forms of parasite with inflammatory host leukocytes such as macrophages might quickly modulate the LB formation in the *T. cruzi* (**Figure [2](#F2){ref-type="fig"}**). Moreover, ultrastructural analyses of LBs from amastigote forms inside macrophages, showed the presence of a typical monolayer of phospholipids with varied electron-density, similar for the one of the mammals cells. In addition, the electron density was dependent on the cell activation state and the LBs from the amastigotes inside heart macrophages, during *in vivo* infection, were more electron-dense, than the LBs from peritoneal macrophages, during *in vitro* infection ([@B71]).

Furthermore, it has been showed that the arachidonic acid (AA) is a potent inductor of LB formation in eukaryotic cells ([@B79]; [@B13]) and that these organelles incorporate AA, mostly esterified in phospholipids ([@B77]; [@B78]). Interestingly, trypomastigotes forms of *T. cruzi* stimulated by AA *in vitro* presented an enhanced number of LBs when compared to unstimulated parasites in a time- and dose-dependent manner, with a peak at 24 h of *in vitro* stimulation. Raman spectroscopy and MALDI-TOF mass spectroscopy confirmed that both parasites stimulated by AA can incorporate a higher content of unsaturated fatty acids, such as AA inside parasite LBs ([@B71]). These organelles, formed as the outcome of host interaction, suggest that the high content of AA can be captured from host cell by the parasite (**Figure [2](#F2){ref-type="fig"}**).

Lipid Bodies Are Specialized in the Eicosanoids Synthesis in Both Parasite and Host Cells
=========================================================================================

As described before, LBs can accumulate AA, suggesting that these LBs are potentially efficient to initiate intracellular signaling pathways that culminate in the formation of lipid inflammatory mediators, such as eicosanoids ([@B77]; [@B78]). Prostaglandins (PG) are eicosanoids derived from AA, which are converted by cyclooxygenase (COX-1 and COX-2) into PGH~2~, which in turn is converted *in vivo* and *in vitro* into various arachidonate metabolites, such as PGD~2~, PGE~2~, and PGF~2a~ ([@B34]; [@B52]). The PGE~2~ sustains homeostatic functions and mediates pathogenic mechanisms, including the inflammatory response associated with parasitic disease ([@B41]). In fact, previous works documented LBs as sites of compartmentalization of eicosanoid-forming enzymes ([@B85]; [@B12]; [@B21], [@B20]), and *in situ* production of eicosanoids, such as leukotrienes and prostaglandins, were really identified in these organelles within activated cells during an inflammatory situation ([@B6]; [@B60]; [@B73]; [@B21]).

Earlier works have demonstrated that macrophages infected by *T. cruzi* were positively immunostained for COX-2, and COX-2 expression was increased when macrophages were co-cultured with apoptotic cells ([@B30]; [@B20]). In addition, [@B20] confirmed that COX-2 is localized within LBs as well as in the perinuclear membrane in infected cells. Using Eicosacell technique, a strategy developed for direct *in situ* immunolocalization of eicosanoid synthesis ([@B7]), new formed PGE~2~ was produced in LBs induced by *T. cruzi* infection in the presence of apoptotic cells ([@B20]).

After the findings on the synthesis of PGE~2~ in LB-induced by *T. cruzi* in macrophages, it was showed that LBs from trypomatigotes forms of *T. cruzi*, are capable to incorporate AA and might be sources of PGE~2~ synthesis, suggesting an activation of the AA cascade and a likely pathway for PGE~2~ production in the parasite ([@B71]). Moreover, the parasites produce PGs, like eukaryotic cells possessing the enzymatic machineries for PG biosynthesis ([@B24]; [@B42]; [@B58]). However, the homologs of mammalian COX have not been found in any parasitic protozoan so far, although proteins called COX-like enzymes, that are similar to the mammalian COX-1 and COX-2 have already been identified ([@B42]). Indeed, trypomastigotes forms of *T. cruzi*, stimulated by AA led to quantitative increases in LBs biogenesis in parallel with PGE~2~ secretion and PGE~2~ synthase expression ([@B71]). Thus, the co-localization of LB and PGE~2~ sites within stimulated trypomastigotes, give credence to the LBs as organelles to the sites for newly formed PGE~2~ during the activation ([@B71]). This is also true for the *T. cruzi* infection in macrophages ([@B20]). These data suggest that LBs may be the source of lipid and inflammatory mediators, in response to the host--parasite interaction. Furthermore, PGE~2~ may be a powerful immunomodulator and acts in the immunosuppression that occurs during *T. cruzi* infection, indicating a function for PGs from *T*. *cruzi* in the Chagas disease pathogenesis.

Lipid Body Inhibition as Infection Control Strategy
===================================================

Based on the effects that *T. cruzi* infection and apoptotic cell uptake cause on LBs formation in the host cell, it has been investigated whether modulation of the formation of this organelle could impact the replication of the parasite ([@B20]). It was tested the effect of two non-steroidal anti-inflammatory drugs (NSAIDs), aspirin (COX-1 and COX-2 inhibitor) and NS- 398 (COX-2 inhibitor) which, in addition to their COX inhibitory effect, also inhibit COX-independent LB formation ([@B13], [@B12]). Both aspirin and NS-398 inhibited the LB biogenesis in infected macrophages in the presence or absence of apoptotic cells, suppressing the *T. cruzi* effects on LB-derived PGE~2~ synthesis, and reversing the enhancement on parasite replication induced by apoptotic cells (**Figure [2](#F2){ref-type="fig"}**). Therefore, the biogenesis of the LBs in both the *T. cruzi* infection and in the parasite interaction has a direct role in the ability of the macrophages to synthesize increased amounts of PGE~2~, which may have an impact on the course of the disease ([@B20]).

In parallel, LB biogenesis seems to request *de novo* lipid synthesis in a cellular mechanism controlled by fatty acid synthase ([@B66]; [@B21]; [@B1]). Therefore, the fatty acid synthase inhibitor C75 significantly inhibited LB biogenesis induced by *T. cruzi* infection, with or without the uptake of apoptotic cells, through a mechanism independent of the inhibition of the COX-2 enzyme (**Figure [2](#F2){ref-type="fig"}**). Remarkably, it was demonstrated that the treatment with C75 also reversed the parasite replication in macrophages as well as the formation of LBs ([@B20]).

In conclusion, it is safe to say that these organelles show an important role in the inflammatory response, especially against intracellular pathogens, since their biogenesis leads to the production of inflammatory mediators, suppressing the macrophage effectiveness to respond and reduce its capacity to eliminate the parasite and control the infection. In this mini review, we analyzed the structure, composition and function of the LBs in the parasite and host cell during *T. cruzi* infection ([@B49]; [@B20]). The increases in LB numbers in *T. cruzi*, associated with changes in LB ultrastructure highlight the fact that LBs parasites are also plastic, dynamic and active organelles, which are efficient in modifying their structure and composition in line with immune cell activation mechanisms.

Concluding Remarks
==================

Studies have investigated the intriguing formation of LBs, both in the host cell and in the parasite itself ([@B20]; [@B71]). Newly formed host LBs are distinguished for their efficiency to synthesize lipid inflammatory mediators, such as PGE~2~ and to compartmentalize eicosanoid-forming enzymes, such as COX-2 ([@B85]; [@B12]; [@B21], [@B20]).

Host leukocytes LBs triggered by *T. cruzi* infection and increased by the phagocytosis of apoptotic cells are accepted not only as inflammatory organelles and structural markers of parasite-induced cell activation, but also as organelles efficient in the orchestration of the host cell metabolism ([@B20]). A recent work supports the idea that the *T. cruzi* itself is capable of producing LB-derived PGE~2~ after contact with the host cell to facilitate its own survival ([@B71]). This is evidence that parasites have adapted to their lipid hosts modulation mechanisms by taking advantage of the cellular metabolism favoring the diseases progression. However, the effects of modulating the formation of LBs by distinct drugs and their influence in the control of parasite replication experimentally, suggest mechanisms that could help in the discovery of new effective therapies for Chagas disease.
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